Quisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreIDRA 21是抑制 AMPA 受体脱敏(inhibit desensitization)。
MoreIEM 1460是IEM 1460 is an AMPA currents' open-channel blocker and selective for non-GluR2-containing receptors.。
MoreICI 162,846是活性的 H2 拮抗剂, 体内有效。
MoreIbotenic acid是非选择性 NMDA 激动剂。
More